Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 1 |
2015 | 1 |
2016 | 2 |
2018 | 1 |
2019 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Evaluation of Macitentan in Patients With Eisenmenger Syndrome.
Circulation. 2019 Jan 2;139(1):51-63. doi: 10.1161/CIRCULATIONAHA.118.033575.
Circulation. 2019.
PMID: 30586694
Free PMC article.
Clinical Trial.
Macitentan in pulmonary hypertension due to left ventricular dysfunction.
Vachiéry JL, Delcroix M, Al-Hiti H, Efficace M, Hutyra M, Lack G, Papadakis K, Rubin LJ.
Vachiéry JL, et al. Among authors: efficace m.
Eur Respir J. 2018 Feb 7;51(2):1701886. doi: 10.1183/13993003.01886-2017. Print 2018 Feb.
Eur Respir J. 2018.
PMID: 29437943
Free article.
Clinical Trial.
Item in Clipboard
Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension.
Simonneau G, Torbicki A, Hoeper MM, Delcroix M, Karlócai K, Galiè N, Degano B, Bonderman D, Kurzyna M, Efficace M, Giorgino R, Lang IM.
Simonneau G, et al. Among authors: efficace m.
Eur Respir J. 2012 Oct;40(4):874-80. doi: 10.1183/09031936.00137511. Epub 2012 Feb 23.
Eur Respir J. 2012.
PMID: 22362844
Free article.
Clinical Trial.
Item in Clipboard
FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion.
Berger RM, Haworth SG, Bonnet D, Dulac Y, Fraisse A, Galiè N, Ivy DD, Jaïs X, Miera O, Rosenzweig EB, Efficace M, Kusic-Pajic A, Beghetti M.
Berger RM, et al. Among authors: efficace m.
Int J Cardiol. 2016 Jan 1;202:52-8. doi: 10.1016/j.ijcard.2015.08.080. Epub 2015 Aug 9.
Int J Cardiol. 2016.
PMID: 26386921
Clinical Trial.
Item in Clipboard
Corrigendum to "FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion" [Int. J. Cardiol. 202 (2016) 52-58].
Berger RMF, Haworth SG, Bonnet D, Dulac Y, Fraisse A, Galiè N, Ivy DD, Jaïs X, Miera O, Rosenzweig EB, Efficace M, Kusic-Pajic A, Beghetti M.
Berger RMF, et al. Among authors: efficace m.
Int J Cardiol. 2016 Nov 15;223:1072-1073. doi: 10.1016/j.ijcard.2016.08.333. Epub 2016 Aug 24.
Int J Cardiol. 2016.
PMID: 27623401
No abstract available.
Item in Clipboard
Cite
Cite